Lung Neoplasms  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00268151: Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

Terminated
1
24
US
Oxaliplatin, Capecitabine
University of Louisville, James Graham Brown Cancer Center, Sanofi
Carcinoma, Non-Small Cell Lung
02/07
 

Download Options